Stay updated on Nintedanib for Progressive Fibrosing ILD Clinical Trial
Sign up to get notified when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.

Latest updates to the Nintedanib for Progressive Fibrosing ILD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now shows the full study record for the PF-ILD trial, replacing the previous error page and adding the study overview, design, outcomes, and list of participating sites.SummaryDifference100%

- Check16 days agoChange DetectedThe revision label on the page was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's documentation/versioning. No study data or essential content appears to be changed.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision was bumped from v3.6.3 to v3.6.4, representing a small update to the page's metadata without changing the study details.SummaryDifference0.0%

- Check44 days agoChange DetectedPublication record updated: the Walters et al. cost-effectiveness paper moved from May 2026 online-ahead-of-print to the final July 2026 print publication in the Publications section of the study page.SummaryDifference0.0%

- Check52 days agoChange DetectedThe study record now shows revision v3.6.3 for the study documents, replacing the previous v3.6.2; this reflects an updated version of the study protocol and related materials.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now shows Revision: v3.6.2 instead of Revision: v3.6.0. This reflects a small build or content update to the page.SummaryDifference0.0%

Stay in the know with updates to Nintedanib for Progressive Fibrosing ILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.